Growth Fund invests € 325 million in Oncode-PACT to accelerate the development of cancer drugs
4/22/2022The National Growth Fund invests € 325 million in the Oncode-PACT plan to accelerate the preclinical development process of cancer drugs. Several Medical Delta researchers are affiliated with Oncode-PACT.